Adolescent

Nephrology·MeSH: Psychological Well-Being

15 drugs in development·14 companies·5 clinical trials

Drug Pipeline by Phase

Approved(12)

Drug	Company
almotriptan malate	Mylan II B.V. (MYL)
ASCENIV	ADMA BIOLOGICS, INC. (ADMA)
azelastine	Amneal Pharmaceuticals, Inc. (AMRX)
dextroamp saccharate	ANI PHARMACEUTICALS INC (ANIP)
Ebglyss	ELI LILLY & Co (LLY)
Ebglyss®	ELI LILLY & Co (LLY)
Galafold	AMICUS THERAPEUTICS, INC. (FOLD)
litfulo	PFIZER INC (PFE)
medroxyprogesterone	Amphastar Pharmaceuticals, Inc. (AMPH)
paliperidone	Inventiva S.A. (IVA)
pemgarda	Invivyd, Inc. (IVVD)
somatrogon	OPKO HEALTH, INC. (OPK)

Phase 3(2)

Drug	Company
voclosporin	Aurinia Pharmaceuticals Inc. (AUPH)
WAKIX (pitolisant) - Prader-Willi Syndrome (PWS)	Harmony Biosciences Holdings, Inc. (HRMY)

Phase 4(1)

Drug	Company
AbobotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 15 drugs in development for Adolescent across 14 companies.

There are 5 clinical trials targeting Adolescent tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.